Director Declaration

RNS Number : 6064Y

Circassia Pharmaceuticals Plc

09 September 2015

 



For immediate release

Circassia Pharmaceuticals plc

Director Declaration

9 September 2015

In accordance with Listing Rule 9.6.14 (2), the Company announces that Paul R Edick, a Non-Executive Director of Circassia Pharmaceuticals plc (LSE: CIR), was appointed as a Non-Executive Director of PDL BioPharma Inc (NASDAQ: PDLI) on 8 September 2015.  He was also appointed in June 2015 as a Non-Executive Director of Neos Therapeutics Inc, which closed its initial public offering (NASDAQ: NEOS) on 28 July 2015. 

-Ends-

For further information, please contact:
Circassia Pharmaceuticals plc Julien Cotta, Company Secretary	[phone]

 

END

 

 

RDNLLMFTMBAMBJA